Physician

Andrew William Pieleck, D.O.

According to 2025 Medicare claims, Andrew Pieleck, D.O. (NPI: 1821226937) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is ACCESS HEALTHCARE MULTI-SPECIALTY GROUP, PLLC (NPI: 1245709088; TIN: 831045228) and primary practice location at 24551-2675. Pieleck is affiliated with the Aledade 94 VA MSSP Enhanced (ACO ID: A4996), participating under the MSSP model.

Pieleck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 582 traditional Medicare patients, billed 4,034 HCPCS/CPT codes, and received $218,841 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,792 prescription claims across 646 beneficiaries totaling $543,498 in drug costs, led by Ozempic (Semaglutide). DME data shows 449 claims. Open Payments data shows 18 records totaling $336. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $87,200 to $218,841. Similarly, Part D prescription costs have moved sharply higher in recent years, from $123,149 to $543,498. In contrast, DME billing represents a smaller volume and rose steadily, from $2,113 to $29,224.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	445	2,338	$87,200
2016	591	3,821	$125,323
2017	416	3,022	$87,805
2018	324	1,220	$65,794
2019	432	3,051	$117,454
2020	394	3,440	$142,758
2021	792	5,399	$239,721
2022	540	5,080	$234,120
2023	545	3,363	$207,343
2024	582	4,034	$218,841

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	350	2,922	$123,149
2016	438	3,565	$131,337
2017	359	2,436	$80,536
2018	411	1,078	$37,366
2019	386	2,889	$145,919
2020	359	3,771	$241,838
2021	447	4,934	$377,971
2022	511	5,981	$466,191
2023	532	6,600	$545,203
2024	646	7,792	$543,498

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	29	$482
2016	11	46	$4,374
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	36	$419
2020	14	50	$685
2021	13	106	$2,294
2022	41	209	$7,519
2023	71	275	$11,944
2024	78	449	$23,981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	333	333	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	507	1,076	$76
99497	Advance care planning, first 30 minutes	291	292	$73
G0008	Administration of influenza virus vaccine	139	139	$31
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	201	307	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	52	2,118	$68,916
Xarelto	Rivaroxaban	45	3,390	$62,610
Eliquis	Apixaban	57	2,672	$49,364
Januvia	Sitagliptin Phosphate	20	1,800	$31,142
Mounjaro	Tirzepatide	29	818	$30,447

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	18	$7,196
E0601	Continuous positive airway pressure (cpap) device	Y	11	83	$2,521
A7031	Face mask interface, replacement for full face mask, each	N	N/R	28	$2,433
A7030	Full face mask used with positive airway pressure device, each	N	N/R	29	$2,228
E1161	Manual adult size wheelchair, includes tilt in space	Y	N/R	11	$2,215

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$336	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew William Pieleck, D.O.?

Tedicare shows public-source Medicare data for Andrew William Pieleck, D.O. (NPI 1821226937), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew William Pieleck, D.O. have ACO affiliation data?

Andrew William Pieleck, D.O. is shown with ACO affiliation data for Aledade 94 VA MSSP Enhanced (MSSP, ACO ID A4996).

What billing organization is linked to Andrew William Pieleck, D.O.?

Andrew William Pieleck, D.O. is linked to ACCESS HEALTHCARE MULTI-SPECIALTY GROUP, PLLC (billing NPI 1245709088) in the available physician profile data.

Does Andrew William Pieleck, D.O. have Open Payments data?

Andrew William Pieleck, D.O. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.